Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1.9M |
| Cost of revenue | $0 | $0 | $0 | $818.1K |
| Gross profit | $0 | $0 | $0 | $1.1M |
| Gross margin | — | — | — | 57.2% |
| R&D | $0 | $0 | $90.0K | $788.9K |
| Operating income | −$467.4K | −$1.7M | −$1.2M | −$7.1M |
| EBITDA | −$467.4K | $0 | −$560.7K | −$6.8M |
| Net income | −$329.4K | $205.0K | −$1.3M | −$6.9M |
| Net margin | — | — | — | -361.0% |
| EPS (diluted) | -0.03 | 0.01 | -0.06 | -4.83 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ALPAU.
No tracked institution reports a position in ALPAU as of their last filing.
No one on the platform has traded ALPAU yet.
| -1.56% |
| $158M |
| — |
| NFYSEnphys Acquisition Corp. | $11.00 | +0.09% | $164M | — |
| RENECartesian Growth Corporation II | $11.75 | +0.00% | $155M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.